KRYS
Krystal Biotech·NASDAQ
--
--(--)
--
--(--)
6.78 / 10
Outperform
Analyst consensus is 100% Strong Buy from four firms, though historical win rates vary. Sentiment scores 6.78 (Outperform) and fund‑flow rating is good (7.93), with overall and block inflows positive but small‑to‑large flows negative. Overall sentiment leans bullish.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-25
InstitutionGuggenheim
Times predicted2
Historical Win Rate0.0%
What is the market sentiment for KRYS?
- KRYS holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.78/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
